approval
saveDENOSUMAB-DSSB — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 1
same company · ±60 days · 6
- approvalinfliximab biosimilar: RENFLEXIS (INFLIXIMAB-ABDA) — FDA approvalOct 28, 2025
- recallSamsung Bioepis Co., Ltd. recall (Cls II)Nov 5, 2025
- approvalHADLIMA: HADLIMA (ADALIMUMAB-BWWD) — FDA approvalOct 17, 2025
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 10, 2025
- approvalBYOOVIZ: BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalNov 12, 2025
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalNov 18, 2025
comments(0)
5-min edit window · permanent after that